Hepatocytic transcriptional signatures predict comparative drug interaction potential of rifamycin antibiotics
出版年份 2020 全文链接
标题
Hepatocytic transcriptional signatures predict comparative drug interaction potential of rifamycin antibiotics
作者
关键词
-
出版物
Scientific Reports
Volume 10, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-28
DOI
10.1038/s41598-020-69228-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Advances in the diagnosis and treatment of latent tuberculosis infection
- (2020) Ye Eun (Grace) Jung et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Plasma and intracellular pharmacokinetics of tenofovir disoproxil fumarate and emtricitabine in transgender women receiving feminizing hormone therapy
- (2020) Lauren R Cirrincione et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
- (2019) Susan Swindells et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing the lymphoid tissue bioavailability of antiretrovirals in human primary lymphoid endothelial cells and in mice
- (2019) Shetty Ravi Dyavar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Protein Binding of First-Line Antituberculosis Drugs
- (2018) Wael A. Alghamdi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
- (2018) Simon Tiberi et al. LANCET INFECTIOUS DISEASES
- Mycobacterium tuberculosis
- (2018) Anastasia Koch et al. TRENDS IN MICROBIOLOGY
- Normalization of cell associated antiretroviral drug concentrations with a novel RPP30 droplet digital PCR assay
- (2018) Shetty Ravi Dyavar et al. Scientific Reports
- Regulation of drug-metabolizing enzymes in infectious and inflammatory disease: implications for biologics–small molecule drug interactions
- (2017) Pankajini Mallick et al. Expert Opinion on Drug Metabolism & Toxicology
- Clinical and pharmacological hallmarks of rifapentine’s use in diabetes patients with active and latent tuberculosis: do we know enough?
- (2017) Chunlan Zheng et al. Drug Design Development and Therapy
- Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis
- (2015) K L Winthrop et al. ANNALS OF THE RHEUMATIC DISEASES
- Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention
- (2015) Anthony T. Podany et al. CLINICAL INFECTIOUS DISEASES
- Detecting latent tuberculosis in compromised patients
- (2015) Ilaria Sauzullo et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus
- (2015) Katharina Ronacher et al. IMMUNOLOGICAL REVIEWS
- Clinical assessment of drug-drug interactions of tasimelteon, a novel dual melatonin receptor agonist
- (2015) Brian W. Ogilvie et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Determination of the rifamycin antibiotics rifabutin, rifampin, rifapentine and their major metabolites in human plasma via simultaneous extraction coupled with LC/MS/MS
- (2015) Lee C. Winchester et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Parsing interindividual drug variability: an emerging role for systems pharmacology
- (2015) Richard M. Turner et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Treatment Optimization in Patients Co-Infected with HIV and Mycobacterium tuberculosis Infections: Focus on Drug–Drug Interactions with Rifamycins
- (2014) Mario Regazzi et al. CLINICAL PHARMACOKINETICS
- Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine
- (2013) Beth Williamson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Causal analysis approaches in Ingenuity Pathway Analysis
- (2013) Andreas Krämer et al. BIOINFORMATICS
- Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers
- (2013) M. Weiner et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
- (2013) Ulrich M. Zanger et al. PHARMACOLOGY & THERAPEUTICS
- PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques
- (2012) Ravi Dyavar Shetty et al. JOURNAL OF CLINICAL INVESTIGATION
- World Health Organization Group 5 Drugs for the Treatment of Drug-Resistant Tuberculosis: Unclear Efficacy or Untapped Potential?
- (2012) K. E. Dooley et al. JOURNAL OF INFECTIOUS DISEASES
- Tuberculosis and the risk of opportunistic infections and cancers in HIV-infected patients starting ART in Southern Africa
- (2012) Lukas Fenner et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
- Predictive Utility of In Vitro Rifampin Induction Data Generated in Fresh and Cryopreserved Human Hepatocytes, Fa2N-4, and HepaRG Cells
- (2011) I. E. Templeton et al. DRUG METABOLISM AND DISPOSITION
- Tuberculosis and cancer: a complex and dangerous liaison
- (2011) Sandro Vento et al. LANCET ONCOLOGY
- Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
- (2011) Timothy R. Sterling et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Pregnane X Receptor (NR1I2) and CYP2B6 Genetic Polymorphisms on the Induction of Bupropion Hydroxylation by Rifampin
- (2010) J. Y. Chung et al. DRUG METABOLISM AND DISPOSITION
- Lack of a Clinically Meaningful Pharmacokinetic Effect of Rifabutin on Raltegravir: In Vitro/In Vivo Correlation
- (2010) Diana M. Brainard et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression
- (2010) A. Git et al. RNA
- Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir
- (2009) L. A. Wenning et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Polymorphism of human cytochrome P450 enzymes and its clinical impact
- (2009) Shu-Feng Zhou et al. DRUG METABOLISM REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now